Congenital diaphragmatic hernia, or CDH, is one of the most common birth defects, affecting about one in 2,500 newborns today. CDH occurs when the diaphragm develops abnormally during gestation (around week 7-8), creating a defect, or hole, through which organs such as the intestines migrate into the chest. The result is compression and impairment in the development of the lungs, including pulmonary hypertension, a dangerous condition involving high blood pressure in the lungs. Among babies with CDH, pulmonary hypertension can lead to heart failure and is the most significant cause of illness and death. Fortunately, medicine has made tremendous progress against pulmonary hypertension during the past 25 years.

References:
(1) Lally, Kevin, MD. “Congenital Diaphragmatic Hernia: Toward Better Evidence-Based Management.” Children’s Memorial Hermann Physicians Advance: Advancing the Frontiers of Medicine (Jan, 2007) A3
(2) Ibid, A2
(3)Deprest, Jan, MD; Jani, Jacques, MD; Gratacos, Eduardo, MD, Vandecruys, Hilde, MD, Naulaers, Gunnar, MD; Delgado, Julian, MD; Greenough, Anne, MD; Nicolaides, Kypros, MD; and The FETO Task Group. “Fetal Intervention for Congenital Diaphragmatic Hernia: The European Experience.” Seminars in Perinatology 29:2 (2005) 95
(4) Lally, Kevin, MD. “Congenital Diaphragmatic Hernia: Toward Better Evidence-Based Management.” Children’s Memorial Hermann Physicians Advance: Advancing the Frontiers of Medicine (Jan, 2007) A2
(5) Deprest, Jan, MD; Jani, Jacques, MD; Gratacos, Eduardo, MD, Vandecruys, Hilde, MD, Naulaers, Gunnar, MD; Delgado, Julian, MD; Greenough, Anne, MD; Nicolaides, Kypros, MD; and The FETO Task Group. “Fetal Intervention for Congenital Diaphragmatic Hernia: The European Experience.” Seminars in Perinatology 29:2 (2005) 95